HIGHLIGHTS
- who: Chengming Liu from the Department of Thoracic Surgery, National Cancer Center/National Clinical Sciences and Peking Union Medical College, Beijing, China have published the research work: Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer, in the Journal: (JOURNAL)
- what: The authors aimed to identify the key cytokines which influenced the responses and stimulated resistance to ICIs and tried to improve immunological response and develop novel clinical treatments in non-small cell lung cancer (NSCLC). The authors explored the association between . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.